283 related articles for article (PubMed ID: 27311186)
1. [IL-6 blockade].
Kaneko Y; Takeuchi T
Nihon Rinsho; 2016 Jun; 74(6):963-7. PubMed ID: 27311186
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab for the treatment of rheumatoid arthritis.
Tanaka T; Ogata A; Narazaki M
Expert Rev Clin Immunol; 2010 Nov; 6(6):843-54. PubMed ID: 20979549
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab in the treatment of rheumatoid arthritis and beyond.
Shetty A; Hanson R; Korsten P; Shawagfeh M; Arami S; Volkov S; Vila O; Swedler W; Shunaigat AN; Smadi S; Sawaqed R; Perkins D; Shahrara S; Sweiss NJ
Drug Des Devel Ther; 2014; 8():349-64. PubMed ID: 24729685
[TBL] [Abstract][Full Text] [Related]
4. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
Raimondo MG; Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2017; 11():1593-1603. PubMed ID: 28579757
[TBL] [Abstract][Full Text] [Related]
5. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.
Nishimoto N; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Azuma J; Kishimoto T
Mod Rheumatol; 2009; 19(1):12-9. PubMed ID: 18979150
[TBL] [Abstract][Full Text] [Related]
6. [Humanized anti-human IL-6 receptor antibody, tocilizumab].
Nishimoto N
Nihon Rinsho; 2007 Jul; 65(7):1218-25. PubMed ID: 17642235
[TBL] [Abstract][Full Text] [Related]
7. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
[TBL] [Abstract][Full Text] [Related]
8. [Clinical benefits of anti-human IL-6 receptor antibody therapy].
Nishimoto N
Clin Calcium; 2007 Apr; 17(4):562-8. PubMed ID: 17404486
[TBL] [Abstract][Full Text] [Related]
9. [Tocilizumab in rheumatoid arthritis].
Rueda Gotor J; Blanco Alonso R
Reumatol Clin; 2011 Mar; 6S3():S29-32. PubMed ID: 21794769
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab: A Review in Rheumatoid Arthritis.
Scott LJ
Drugs; 2017 Nov; 77(17):1865-1879. PubMed ID: 29094311
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.
Ingegnoli F; Tourlaki A; Gualtierotti R
Clin Drug Investig; 2014 Feb; 34(2):159-61. PubMed ID: 24307431
[TBL] [Abstract][Full Text] [Related]
12. Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis.
Lamb YN; Deeks ED
Drugs; 2018 Jun; 78(9):929-940. PubMed ID: 29931592
[TBL] [Abstract][Full Text] [Related]
13. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
Maini RN; Taylor PC; Szechinski J; Pavelka K; Bröll J; Balint G; Emery P; Raemen F; Petersen J; Smolen J; Thomson D; Kishimoto T;
Arthritis Rheum; 2006 Sep; 54(9):2817-29. PubMed ID: 16947782
[TBL] [Abstract][Full Text] [Related]
14. Targeting interleukin-6 in rheumatoid arthritis.
Md Yusof MY; Emery P
Drugs; 2013 Mar; 73(4):341-56. PubMed ID: 23456676
[TBL] [Abstract][Full Text] [Related]
15. New biologics for rheumatoid arthritis.
Choy E
J R Coll Physicians Edinb; 2011 Sep; 41(3):234-7. PubMed ID: 21949922
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab: the first interleukin-6-receptor inhibitor.
Sebba A
Am J Health Syst Pharm; 2008 Aug; 65(15):1413-8. PubMed ID: 18653811
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous tocilizumab for the treatment of rheumatoid arthritis.
Mitchell E; Jones G
Expert Rev Clin Immunol; 2016; 12(2):103-14. PubMed ID: 26629984
[TBL] [Abstract][Full Text] [Related]
18. Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis.
Gómez-Reino J
Rheumatology (Oxford); 2012 Jul; 51 Suppl 5():v31-7. PubMed ID: 22718925
[TBL] [Abstract][Full Text] [Related]
19. The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
Narazaki M; Tanaka T; Kishimoto T
Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214
[TBL] [Abstract][Full Text] [Related]
20. A review of sarilumab for the treatment of rheumatoid arthritis.
Lee EB
Immunotherapy; 2018 Jan; 10(1):57-65. PubMed ID: 29043871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
